← Back to home

CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS

Clinical trials for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS explained in plain language.

Never miss a new study

Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS trials appear

Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to stop Chemotherapy's dangerous blood side effect

Disease control Recruiting now

This study is testing if a drug called hetrombopag can safely prevent a dangerous drop in platelets (cells that help blood clot) caused by chemotherapy in people with stomach, colon, or other gastrointestinal cancers. It will enroll 40 patients who are at risk for this side effec…

Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS

Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS

Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS trials appear

New pill aims to stop Chemotherapy's dangerous blood side effect